BCDA Valuation

BioCardia Inc

Add to Watchlist

Advanced Chart

1.880

-0.04(-2.083%)1D

Overview
Forecast
Valuation
Earnings

BCDA Relative Valuation

BCDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BCDA is overvalued; if below, it's undervalued.

Historical Valuation

BioCardia Inc (BCDA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.06. The fair price of BioCardia Inc (BCDA) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.88

Fair

-1.87

Trailing

Forward

0.00

EV/EBITDA

BioCardia Inc. (BCDA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -1.17. The thresholds are as follows: Strongly Undervalued below -3.51, Undervalued between -3.51 and -2.34, Fairly Valued between -0.00 and -2.34, Overvalued between -0.00 and 1.16, and Strongly Overvalued above 1.16. The current Forward EV/EBITDA of 0.00 falls within the Overvalued range.

-1.09

EV/EBIT

BioCardia Inc. (BCDA) has a current EV/EBIT of -1.09. The 5-year average EV/EBIT is -1.49. The thresholds are as follows: Strongly Undervalued below -3.31, Undervalued between -3.31 and -2.40, Fairly Valued between -0.58 and -2.40, Overvalued between -0.58 and 0.33, and Strongly Overvalued above 0.33. The current Forward EV/EBIT of -1.09 falls within the Historic Trend Line -Fairly Valued range.

0.00

BioCardia Inc. (BCDA) has a current PS of 0.00. The 5-year average PS is 126.15. The thresholds are as follows: Strongly Undervalued below -252.59, Undervalued between -252.59 and -63.22, Fairly Valued between 315.52 and -63.22, Overvalued between 315.52 and 504.89, and Strongly Overvalued above 504.89. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

BioCardia Inc. (BCDA) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.79. The thresholds are as follows: Strongly Undervalued below -3.81, Undervalued between -3.81 and -2.30, Fairly Valued between 0.73 and -2.30, Overvalued between 0.73 and 2.24, and Strongly Overvalued above 2.24. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

BioCardia Inc. (BCDA) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.05. The thresholds are as follows: Strongly Undervalued below -2.70, Undervalued between -2.70 and -1.37, Fairly Valued between 1.28 and -1.37, Overvalued between 1.28 and 2.61, and Strongly Overvalued above 2.61. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

BioCardia Inc (BCDA) has a current Price-to-Book (P/B) ratio of -5.60. Compared to its 3-year average P/B ratio of 2.18 , the current P/B ratio is approximately -356.69% higher. Relative to its 5-year average P/B ratio of 2.96, the current P/B ratio is about -289.40% higher. BioCardia Inc (BCDA) has a Forward Free Cash Flow (FCF) yield of approximately -75.91%. Compared to its 3-year average FCF yield of -68.42%, the current FCF yield is approximately 10.95% lower. Relative to its 5-year average FCF yield of -52.85% , the current FCF yield is about 43.64% lower.

-5.60

P/B

Median3y

2.18

Median5y

2.96

-75.91

FCF Yield

Median3y

-68.42

Median5y

-52.85

Competitors Valuation Multiple

The average P/S ratio for BCDA's competitors is 3.55, providing a benchmark for relative valuation. BioCardia Inc Corp (BCDA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Leap Therapeutics Inc

Loss

11.95M

SNSE.O

Sensei Biotherapeutics Inc

Performance Decomposition

Market capitalization of BCDA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of BCDA in the past 1 year is driven by Unknown.